Comparison of fluorine-18-FDG PET and thallium-201 SPECT in evaluation of lung cancer

Journal of Nuclear Medicine

Volumn 39, Issue 1, 1998, Pages 9-15

  Higashi, Kotaro ^a   Nishikawa, Takahiro ^b   Seki, Hiroyasu ^b   Oguchi, Manabu ^b   Nambu, Yoshihiro ^b   Ueda, Yoshimichi ^b   Yuasa, Kokichi ^b   Tonami, Hisao ^b   Okimura, Tetsuro ^b   Yamamoto, Itaru ^b  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

Fluorine 18 fluorodeoxyglucose; Lung cancer; PET; Thallium 201

Indexed keywords

FLUORODEOXYGLUCOSE F 18; THALLIUM 201;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MALE; MEDIASTINUM LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THORACOTOMY;

ADENOCARCINOMA; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORINE RADIOISOTOPES; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MEDIASTINUM; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; THALLIUM RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0031883113     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Stanley K, Stjernsward J. Lung cancer. In: Hansen HH, ed. Basic and clinical concepts of lung cancer. Norwell, MA: Kluwer; 1989:1-4.
2. Webb WR, Gatsonis C, Zerhouni EA, et al. CT and MR imaging in non-small cell bronchogenic carcinoma: report of the Radiologic Diagnostic Oncology Group. Radiology 1991;178:705-713.
3. Swensen SJ, Brown LR, Colby TV, Weaver AL. Pulmonary nodules: CT evaluation of enhancement with iodinated contrast material. Radiology 1995;194:393-398.
4. Yamashita K, Matsunobe S, Takahashi R, et al. Small peripheral lung carcinoma evaluated with incremental dynamic CT: radiologic-pathologic correlation. Radiology 1995;196:401-408.
5. Swensen SJ, Brown LR, Colby TV, et al. Lung nodule enhancement at CT: prospective finding. Radiology 1996;201:447-455.
6. Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of lung tumor with positron emission tomography: a prospected study. J Nucl Med 1990;31:1927-1933.
7. Gupta NC, Frank AR, Dewan NA, et al. Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-Fluoro-2-deoxy-D-glucose. Radiology 1992;184: 441-444.
8. Patz EF, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993;188:487-490.
9. Nolop KB, Rhodes CG, Brudine LH, et al. Glucose utilization in vivo by human pulmonary neoplasms. Cancer 1987;60:2682-2689.
10. 18F]fluorodeoxyglucose. Ann Thorac Surg 1994;58:698-703.
11. Patz EF, Lowe VJ, Hoffman JM, Paine SS, Harris LK, Goodman PC. Persistent or recurrent bronchogenic carcinoma: detection with PET and 2-[F-18]-2-deoxy-D-glucose. Radiology 1994;191:379-382.
12. Rege SD, Hoh CK, Glaspy JA, et al. Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose. Cancer 1993;72: 82-90.
13. Dewan NA, Gupta NC, Redepenning LS, Phalen JJ, Frick NP. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Chest 1993;104:997-1002.
14. Gupta NC, Maloof J. Probability of malignancy in solitary nodules using fluorine-18-FDG and PET. J Nucl Med 1996;37:943-948.
15. Wahl RL. Positron emission tomography: applications in oncology. In: Murray IPC, Ell PJ, eds. Nuclear medicine in clinical diagnosis and treatment, Vol. 2, New York: Churchill Livingstone; 1994:801-820.
16. Wahl RL, Quint LE, Greenough RL, Meyer CR, White RI, Orringer MB. Staging of mediastinal non-small cell lung cancer with FDG PET, CT and fusion images: preliminary prospective evaluation. Radiology 1994;191:371-377.
17. Chin R Jr, Ward R, Keyes JW, et al. Mediastinal staging of non-small cell lung cancer (NSCLC) to compare its yield to that of computed tomography (CT). Am J Respir Crit Care Med 1995;152:2090-2096.
18. Sasaki M, Ichiya Y, Kuwabara Y, et al. The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer. Eur J Nucl Med 1996;23:741-747.
19. Tonami N, Shuke N, Yokoyama K, et al. Thallium-201 single photon emission computed tomography in the evaluation of suspected lung cancer. J Nucl Med 1989;30:997-1004.
20. Matsuno S, Tanabe M, Kawasaki Y, et al. Effectiveness of planar image and single photon emission tomography of thallium-201 compared with gallium-67 in patients with primary lung cancer. Eur J Nucl Med 1992;19:86-95.
21. Namba R, Narabayashi I, Matsui R, et al. Evaluation of Tl-201 SPECT for monitoring the treatment of pulmonary and mediastinal tumors. Ann Nucl Med 1995;9:65-74.
22. 99mTc-labeled hexamethyl-propyleneamine-oxime. Ann Nucl Med 1992;6:253-260.
23. Abdel-Dayem HM, Scott A, Macapinlac H, Larson S. Tracer imaging in lung cancer. Eur J Nucl Med 1994;21:57-81.
24. Chin BB, Zukerberg BW, Buchpiguel C, Alavi A. Thallium-201 uptake in lung cancer. J Nucl Med 1995;36:1514-1519.
25. Yokoi K, Okuyama A, Nori K, Tominaga K, Miyazawa N, Takizawa I, Sasawaga M. Mediastinal lymph node metastasis from lung cancer: evaluation with Tl-201 SPECT. Comparison with CT. Radiology 1994;192:813-817.
26. Ando A, Ando I, Katayama M, et al. Biodistributions of Tl-201 in tumor-bearing animals and inflammatory lesion induced animals. Eur J Nucl Med 1987;12:567-572.
27. Ishibashi M, Taguchi A, Sugita Y, et al. Thallium-201 in brain tumors: relationship between tumor cell activity in astrocytic tumor and proliferating cell nuclear antigen. J Nucl Med 1995;36:2201-2206.
28. Oriuchi N, Mamura M, Shibazaki T, et al. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: relationship to histologic grade, prognosis and proliferative activity. J Nucl Med 1993;34:2085-2089.
29. Britten JS, Blamk M. Thallium activation of the (Na+-K+) activated ATPase of rabbit kidney. Biochem Biophys Acta 1968;159:160-166.
30. Sessler MJ, Geek P, Maul FD, et al. New aspects of cellular mechanism of ion uptake: K+Na+-2Cl-cotransport is the central mechanism of ion uptake. Nuklearmedizin 1986;25:24-27.
31. Muranaka A. Accumulation of radioisotopes with tumor affinity. II. Comparison of the tumor accumulation of Ga-67 citrate and thallium-201 chloride in vitro. Acta Med Okayama 1981;35:85-101.
32. Inokuma T, Tamaki N, Torizuka T, et al. Value of fluorine-18-fluorodeoxyglucose and thallium-201 in the detection of pancreatic cancer. J Nucl Med 1995;36:229-235.
33. Buchpiguel CA, Alavi JB, Alavi A, Kenyon LC. PET versus SPECT in distinguishing radiation necrosis from tumor recurrence in the brain. J Nucl Med 1995;36:159-164.
34. 18F fluorodeoxyglucose PET. Am J Roentgenol 1994;163:1459-1465.
35. Oriuchi N, Tomiyama K, Inoue T, et al. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma. J Nucl Med 1996;37:457-462.
36. Hoh CK, Khanna S, Harris GC, et al. Evaluation of brain tumor recurrence with Tl-201 SPECT studies: correlation with FDG PET and histological results [Abstract]. J Nucl Med 1992;33:867.
37. Kubota K, Matsuzawa T, Ito M, et al. Lung tumor imaging by positron emission tomography using C-11-L-methionine. J Nucl Med 1985;26:37-42.
38. Lowe VJ, Hoffman JM, Delong DM, Patz EF, Coleman RE. Semiquantitative and Visual analysis of FDG PET images in pulmonary abnormalities. J Nucl Med 1994;35:1771-1776.
39. Mori K, Yokoi K, Saito Y, Tominaga K, Miyazawa N. Diagnosis of mediastinal lymph node metastases in lung cancer. Jpn J Clin Oncol 1992;22:35-40.
40. Keyes JW. SUV: standard uptake or silly useless value? J Nucl Med 1995;36:1836-1839.
41. 201Tl single-photon emission computed tomography. Nucl Med Commun 1993;14:602-610.
42. 201Tl accumulation on single photon emission computed tomography in benign and malignant thoracic lesions. Nucl Med Commun 1993;14:1071-1078.
43. Orihashi N, Mita T, Uchisaka H, Suga K, Matsumoto T, Nakanishi T. Tl-201 SPECT in the evaluation of small nodular lesions of lung. Jap J Clin Radiol 1994;39:159-163.
44. Martin WH, Delbeke D, Patton JA, Sandler MP. Detection of malignancies with SPECT versus PET, with 2-[Fluorine-18]fluoro-2-deoxy-D-glucose. Radiology 1996; 198:225-231.
45. Drane WE, Abbott FD, Nicole MW, Mastin ST, Kuperus JH. Technology for FDG SPECT with a relatively inexpensive gamma camera. Radiology 1994;191:461-465.
46. Macfarlane DJ, Cotton L, Ackermann RJ, et al. Triple-head SPECT with 2-[fluorine-18] fluoro-2-deoxy-D-glucose (FDG): initial evaluation in oncology and comparison with FDG PET. Radiology 1995;194:425-429.
47. Slosman DO, Pugin J. Lack of correlation between tritiated deoxyglucose, thallium-201 and technetium-99m-MIBI cell incorporation under various cell stresses. J Nucl Med 1994;35:120-126.
48. Kubota R, Kubota K, Yamada S, et al. Active and passive mechanisms of [fluorine-18] fluorodeoxyglucose uptake by proliferating and prenecrotic cancer cells in vivo: a microautoradiographic study. J Nucl Med 1994;35:1067-1075.
49. Higashi K, Clavo AC, Wahl RL. Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med 1993;34:414-419.